Coronavirus Update: Novavax Vaccine Shows High Effectiveness Against Variants

Plus: Korea Makes Vaccine Plan, AZ To Produce In Japan

The vaccine is 95.6% effective at preventing infection with the original COVID-19 strain and 85.6% effective at protecting against the B.1.1.7 strain, with an overall level of protection across the strains of 89.3%. Meanwhile, South Korea has drawn up a national vaccination plan and AstraZeneca is set to produce doses of its vaccine in Japan.

Novavax vaccine
Novavax Vaccine Shows Promise Against Variants • Source: Shutterstock

Novavax, Inc.’s vaccine against SARS-CoV-2 is effective at preventing infection with the UK and South African variant strains of the virus, according to new study results, but consistent with other vaccine results, the protection is lower than against the original strain.

The Gaithersburg, MD-based company released data from two studies, a Phase III study in the UK and a Phase IIb...

Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from COVID-19

More from Scrip